Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol.
about
Vitamin D and anemia: insights into an emerging associationBudget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital.Vitamin D and Clinical Outcomes in Dialysis.Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.
P2860
Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@en
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@nl
type
label
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@en
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@nl
prefLabel
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@en
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@nl
P2093
P2860
P356
P1476
Comparison of erythropoietin r ...... , cinacalcet, or paricalcitol.
@en
P2093
Baris Afsar
Erhan Agca
Suleyman Turk
P2860
P304
P356
10.1002/JCPH.556
P577
2015-07-14T00:00:00Z